Taprizosin free base T28922
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Taprizosin, an alpha1A-adrenoceptor antagonist, is used potentially for the treatment of benign prostatic hyperplasia.
CAS nr:
210538-44-6
Purity:
98%
Molecular Weight:
506,58
SMILES:
CS(=O)(NC1=CC=CC2=C1CCN(C3=NC(N)=C4C(C5=NC=CC=C5)=C(OC)C(OC)=CC4=N3)C2)=O
Formula:
C25H26N6O4S
Pathway:
Target:
